Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Maria Alfieri

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Clinical Medicine|July 13, 2024
Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney DiseaseMatteo Abinti, Simone Vettoretti, Lara Caldiroli, et al.
International Journal of Molecular Sciences|July 27, 2024
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological PerspectivesCarlo Maria Alfieri, Paolo Molinari, Felice Cinque, et al.
Frontiers in Medicine|December 26, 2022
Fibroblast growth factor 23 level modulates the hepatocyte's alpha-2-HS-glycoprotein transcription through the inflammatory pathway TNFα/NFκBDeborah Mattinzoli, Min Li, Giuseppe Castellano, et al.
Journal of Clinical Medicine|December 11, 2022
MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKDDeborah Mattinzoli, Stefano Turolo, Carlo Maria Alfieri, et al.
Journal of Clinical Medicine|September 28, 2023
MCP1 Inverts the Correlation between FGF23 and Omega 6/3 Ratio: Is It Also True in Renal Transplantation?Deborah Mattinzoli, Stefano Turolo, Masami Ikehata, et al.
Pathogens (Basel, Switzerland)|April 30, 2021
Cytomegalovirus Disease in Renal Transplanted Patients: Prevalence, Determining Factors, and Influence on Graft and Patients OutcomesCarlo Maria Alfieri, Paolo Molinari, Mariateresa Gandolfo, et al.
Pathogens (Basel, Switzerland)|May 28, 2022
Prevalence and Risk Factors for Anti-SARS-CoV-2 Antibody in Chronic Kidney Disease (Dialysis Independent and Not)Mariana Siddi, Paolo Molinari, Carlo Maria Alfieri, et al.
Vaccines|July 27, 2022
How Vaccinations Changed the Outcome of COVID-19 Infections in Kidney Transplant Patients: Single-Center ExperienceMariarosaria Campise, Carlo Maria Alfieri, Matteo Benedetti, et al.
Kidney & Blood Pressure Research|June 5, 2026
Inflammatory biomarkers in the assessment of kidney function decline in Long Covid syndromeMargherita Borriello, Roberta Ranieri, Annapaola Coppola, et al.
Archives of Osteoporosis|July 16, 2025
Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologistsMaria Fusaro, Althea Cossettini, Giulia Vanessa Re Sartò, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Clinical Medicine|July 13, 2024
Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney DiseaseMatteo Abinti, Simone Vettoretti, Lara Caldiroli, et al.
International Journal of Molecular Sciences|July 27, 2024
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological PerspectivesCarlo Maria Alfieri, Paolo Molinari, Felice Cinque, et al.
Frontiers in Medicine|December 26, 2022
Fibroblast growth factor 23 level modulates the hepatocyte's alpha-2-HS-glycoprotein transcription through the inflammatory pathway TNFα/NFκBDeborah Mattinzoli, Min Li, Giuseppe Castellano, et al.
Journal of Clinical Medicine|December 11, 2022
MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKDDeborah Mattinzoli, Stefano Turolo, Carlo Maria Alfieri, et al.
Journal of Clinical Medicine|September 28, 2023
MCP1 Inverts the Correlation between FGF23 and Omega 6/3 Ratio: Is It Also True in Renal Transplantation?Deborah Mattinzoli, Stefano Turolo, Masami Ikehata, et al.
Pathogens (Basel, Switzerland)|April 30, 2021
Cytomegalovirus Disease in Renal Transplanted Patients: Prevalence, Determining Factors, and Influence on Graft and Patients OutcomesCarlo Maria Alfieri, Paolo Molinari, Mariateresa Gandolfo, et al.
Pathogens (Basel, Switzerland)|May 28, 2022
Prevalence and Risk Factors for Anti-SARS-CoV-2 Antibody in Chronic Kidney Disease (Dialysis Independent and Not)Mariana Siddi, Paolo Molinari, Carlo Maria Alfieri, et al.
Vaccines|July 27, 2022
How Vaccinations Changed the Outcome of COVID-19 Infections in Kidney Transplant Patients: Single-Center ExperienceMariarosaria Campise, Carlo Maria Alfieri, Matteo Benedetti, et al.
Kidney & Blood Pressure Research|June 5, 2026
Inflammatory biomarkers in the assessment of kidney function decline in Long Covid syndromeMargherita Borriello, Roberta Ranieri, Annapaola Coppola, et al.
Archives of Osteoporosis|July 16, 2025
Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologistsMaria Fusaro, Althea Cossettini, Giulia Vanessa Re Sartò, et al.
Pageof 3